ahlam1399
07-24-2015, 03:33 PM
Sa**fi?s big new cholesterol drug wins European green light
LONDON, July 24 (Reuters) - A new type of cholesterol drug from Sa**fi and Regeneron Pharmaceuticals won a green light from European regulators on Friday, two months behind a rival product from Amgen.
http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2.img (http://da.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/ach.img (http://adchoice.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/ach.htm)http://pi.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2t.imghttp://pi2.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/486759fd/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=x-Gxb4acrKI:qoaPlAE5x4Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x-Gxb4acrKI:qoaPlAE5x4Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=x-Gxb4acrKI:qoaPlAE5x4Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x-Gxb4acrKI:qoaPlAE5x4Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=x-Gxb4acrKI:qoaPlAE5x4Q:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/x-Gxb4acrKI
LONDON, July 24 (Reuters) - A new type of cholesterol drug from Sa**fi and Regeneron Pharmaceuticals won a green light from European regulators on Friday, two months behind a rival product from Amgen.
http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2.img (http://da.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/ach.img (http://adchoice.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/ach.htm)http://pi.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2t.imghttp://pi2.feedsportal.com/r/234566068436/u/49/f/654213/c/35217/s/486759fd/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/486759fd/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=x-Gxb4acrKI:qoaPlAE5x4Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x-Gxb4acrKI:qoaPlAE5x4Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=x-Gxb4acrKI:qoaPlAE5x4Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x-Gxb4acrKI:qoaPlAE5x4Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=x-Gxb4acrKI:qoaPlAE5x4Q:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/x-Gxb4acrKI